107140-32-9

Usage

Uses

Used in Pharmaceutical Industry:
(9S,12S,15S)-9-amino-12-(2-amino-2-oxoethyl)-4-methoxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxylic acid is used as a potential pharmaceutical compound for its complex and unique composition, which may offer novel therapeutic properties and applications in drug development.
Used in Drug Design and Development:
In the field of drug design and development, (9S,12S,15S)-9-amino-12-(2-amino-2-oxoethyl)-4-methoxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxylic acid is used as a structural template for creating new drugs, leveraging its complex molecular architecture to target specific biological pathways or receptors.
Used in Research and Development:
(9S,12S,15S)-9-amino-12-(2-amino-2-oxoethyl)-4-methoxy-10,13-dioxo-2-oxa-11,14-diazatricyclo[15.2.2.1~3,7~]docosa-1(19),3(22),4,6,17,20-hexaene-15-carboxylic acid serves as a subject of research and development in chemical and biological laboratories, where its properties and interactions with biological systems are studied to uncover potential applications in medicine and other related fields.

Upstream product

• 129151-11-7 (9S,12S,15S)-12-(2-Amino-2-oxoethyl)-9-<<(phenylmethoxy)carbonyl>amino>-4-methoxy-10,13-dioxo-2-oxa-11,14-diazatricyclo<15.2.2.1^3,7>docosa-3,5,7(22),17,19,20-hexaene-15-carboxylic acid 
• 118459-80-6 (E,E)-1,1-dimethylethyl 3-<4-<3-oxo-3-(phenylmethoxy)propenyl>phenoxy>-4-methoxybenzenepropenoate 
• 1005-30-7 sodium 4-iodo-benzoate 
• 116523-64-9 (S)-dichlorotyrosine methyl ester hydrochloride 
• 22080-54-2 3,5-dichloro-L-tyrosine ; hydrochloride 
• 60-18-4 L-tyrosine 
• 118459-83-9 (S)-1,1-dimethylethyl 3-<4-<2-azido-3-oxo-3-(phenylmethoxy)propyl>phenoxy>-4-methoxybenzenepropanoate 
• 118629-52-0 (S)-2-Amino-3-{4-[5-(2-carboxy-ethyl)-2-methoxy-phenoxy]-phenyl}-propionic acid benzyl ester 
• 118459-95-3 3-{4-[5-(2-tert-Butoxycarbonyl-ethyl)-2-methoxy-phenoxy]-phenyl}-propionic acid 
• 118459-78-2 (E/Z)-tert-butyl 3-hydroxy-4-methoxycinnamate 
• 118459-79-3 (E)-benzyl 3-(4-bromophenyl)acrylate 
• 75671-82-8 (S)-2-((S)-2-Amino-3-carbamoyl-propionylamino)-3-(4-hydroxy-phenyl)-propionic acid methyl ester 
• 116523-69-4 (9S,12S,15S)-9-tert-Butoxycarbonylamino-12-carbamoylmethyl-4-methoxy-10,13-dioxo-2-oxa-11,14-diaza-tricyclo[15.2.2.1^3,7]docosa-1⁽²⁰⁾,3⁽²²⁾,4,6,17⁽²¹⁾,18-hexaene-15-carboxylic acid methyl ester 
• 192315-61-0 (9S,12S,15S)-9-tert-Butoxycarbonylamino-12-carbamoylmethyl-4-methoxy-10,13-dioxo-2-oxa-11,14-diaza-tricyclo[15.2.2.1^3,7]docosa-1⁽²⁰⁾,3,5,7⁽²²⁾,17⁽²¹⁾,18-hexaene-15-carboxylic acid 

Relevant academic research and scientific papers

Application of Negishi cross-coupling to the synthesis of the cyclic tripeptides OF4949-III and K-13

(Chemical Equation Presented) Syntheses of the cyclic tripeptides OF4949-III 1 and K-13 2 are reported, in which the key steps are intermolecular and intramolecular Negishi cross-coupling reactions, respectively. In addition, the synthesis of a protected

Total synthesis of the cyclic biphenyl ether peptides K-13 and OF494-III via S(N)Ar macrocyclizations of peptidyl ruthenium π-arene complexes

Intramolecular nucleophilic aromatic substitution (S(N)Ar) of preformed ruthenium cyclopentadienyl cationic peptidyl π-complexes forms cyclic biphenyl ethers in convenient, high-yielding reactions. The utility of the method was demonstrated by the efficie

Total Synthesis of L,L-Isodityrosine and Isodityrosine-Derived Agents: K-13, OF4949-III, and OF4949-IV

Full details of the development of reaction conditions for implementation of an activated Ullmann condensation reaction that may be conducted without amino acid racemization and that have proven suitable for incorporation of the selectively protected cate

The total synthesis of the isodityrosine-derived cyclic tripeptides OF4949-III and K-13. Determination of the absolute configuration of K-13

The asymmetric syntheses of the two cyclic tripeptides OF4949-III and K-13 have been completed. The absolute stereochemical assignment of the former compound has been confirmed, while the absolute configuration of the latter has been established for the f